Environmental impact of upstream processing strategies for E. coli-based antibody fragment production: A case study of green metrics versus life cycle assessment

Rüdiger Lück, Oliver Spadiut, Fatima Imran, Michael Harasek, Athanasios Pappas, Konstantina Chatzipanagiotou, George Antonaropoulos, Elias Koumoulos, Stelios Kalogridis, Spiros Chadoulos, Julian Kopp

Open source

DOI
10.1016/j.nbt.2026.09.003
Published
2026-09
Container
New Biotechnology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.nbt.2026.09.003,
  title = {Environmental impact of upstream processing strategies for E. coli-based antibody fragment production: A case study of green metrics versus life cycle assessment},
  author = {Rüdiger Lück and Oliver Spadiut and Fatima Imran and Michael Harasek and Athanasios Pappas and Konstantina Chatzipanagiotou and George Antonaropoulos and Elias Koumoulos and Stelios Kalogridis and Spiros Chadoulos and Julian Kopp},
  year = {2026},
  journal = {New Biotechnology},
  doi = {10.1016/j.nbt.2026.09.003},
  url = {https://doi.org/10.1016/j.nbt.2026.09.003}
}

RIS

TY  - JOUR
TI  - Environmental impact of upstream processing strategies for E. coli-based antibody fragment production: A case study of green metrics versus life cycle assessment
AU  - Rüdiger Lück
AU  - Oliver Spadiut
AU  - Fatima Imran
AU  - Michael Harasek
AU  - Athanasios Pappas
AU  - Konstantina Chatzipanagiotou
AU  - George Antonaropoulos
AU  - Elias Koumoulos
AU  - Stelios Kalogridis
AU  - Spiros Chadoulos
AU  - Julian Kopp
PY  - 2026
JO  - New Biotechnology
DO  - 10.1016/j.nbt.2026.09.003
UR  - https://doi.org/10.1016/j.nbt.2026.09.003
ER  - 

APA

Lück, R., Spadiut, O., Imran, F., Harasek, M., Pappas, A., Chatzipanagiotou, K., Antonaropoulos, G., Koumoulos, E., Kalogridis, S., Chadoulos, S., & Kopp, J. (2026). Environmental impact of upstream processing strategies for E. coli-based antibody fragment production: A case study of green metrics versus life cycle assessment. New Biotechnology. https://doi.org/10.1016/j.nbt.2026.09.003

Source records